Effectiveness and safety of rituximab in special types of rheumatoid arthritis

ConclusionB-cell depletion by rituximab may be a useful treatment option for patients with lymphoproliferative disorder and rheumatoid vasculitis.

Source: International Journal of Rheumatic Diseases - September 14, 2023 Category: Rheumatology Authors: Satoshi Takanashi, Yasushi Kondo, Shuntaro Saito, Jun Kikuchi, Hironari Hanaoka, Tsutomu Takeuchi, Yuko Kaneko Tags: ORIGINAL ARTICLE Source Type: research